Nano-X Imaging Ltd.

NNOX Healthcare Medical Devices

Nano-X Imaging Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $13.0 million, up 15.4% from fiscal 2024. In the quarter to June 2026, revenue grew 36.7%, EPS fell 243.5%, free cash flow fell 21.4% and total debt fell 12.0%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

0.45 0.04 −8.16%
Market cap
$38.6M
P/E
0.0×
Fwd P/E
−2.9×
Dividend yield
—
F-score
3/9
Altman Z
−0.16
Beneish M
n/a
Dividend safety
n/a
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — — — — 6 4 3
P/E ratio
— — — — 0.00 0.00 0.00 0.00 0.00
P/S ratio
— — — — 0.00 43.42 36.76 37.44 13.93
Altman Z-Score
— — — — 4.94 3.55 6.76 9.18 (0.16)
Altman Z″-Score (non-manufacturers)
— — — — 2.63 1.14 4.37 3.91 (3.70)
P/FCF ratio
— — — — 0.00 0.00 0.00 0.00 0.00
P/Operating CF
— — — — (36.31) (25.46) (29.10) (40.11) (17.42)
P/B ratio
— — — — 2.40 1.72 1.86 2.23 1.30
Price to Tangible BV
— — — — 5.31 3.16 3.17 3.55 2.28
EV/Sales
— — — — 0.00 34.86 29.13 32.89 10.66
EV/EBITDA
— — — — 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
— — — — (16.19) (6.89) (6.44) (10.14) (3.40)
EV/FCF
— — — — (10.07) (5.91) (6.00) (9.43) (3.08)
Quick Ratio
— 0.00 0.40 47.65 1.70 3.13 5.41 4.26 3.03
Current Ratio
— 0.21 0.48 49.06 1.80 3.29 5.71 5.63 3.96
Net Debt/EBITDA
— 0.00 0.34 4.85 1.43 1.36 1.85 1.21 0.69
Debt/Assets
0.00% 0.00% 4.43% 0.61% 1.09% 1.66% 1.60% 1.46% 1.93%
Debt/Equity
— 0.00 (0.06) 0.01 0.01 0.02 0.02 0.02 0.02
Asset Turnover
— 0.00 0.00 0.00 0.00 0.03 0.04 0.05 0.07
Operating CF/Net income
— 1.92 0.24 0.49 0.62 0.38 0.74 0.68 0.54
Capex/Depreciation
— (2.09) (2.36) (67.00) (11.16) (0.11) (0.17) (0.24) (0.36)
ROE
— 25.18% 297.63% (39.48%) (23.64%) (44.51%) (29.49%) (27.83%) (45.62%)
ROA
— (205.82%) (328.76%) (35.33%) (20.62%) (36.70%) (25.72%) (24.97%) (40.31%)
ROIC
— 0.00% 0.00% (146.64%) (18.55%) (51.35%) (33.56%) (26.37%) (52.17%)
Return on Tangible Assets
— 29.90% 216.97% (19.11%) (77.69%) (112.20%) (52.64%) (48.62%) (94.27%)
Average Days of Receivables
— — — — 294.18 41.57 54.69 58.39 56.43
Research and Development Expense of Revenue
— 0.00% 0.00% 0.00% 1,313.04% 309.01% 262.99% 178.87% 147.73%
Selling, General and Administrative Expense of Revenue
— 0.00% 0.00% 0.00% 3,201.07% 531.94% 287.13% 229.24% 209.29%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.44 0.39 0.37 0.33 0.37
Share Based Compensation of Revenue
— 0.00% 0.00% 0.00% 1,442.18% 217.10% 69.04% 64.35% 32.18%
Graham Net Nets
— — — — 0.03 0.12 0.18 0.14 0.24
Graham Number
— — — — 0.00 0.00 0.00 0.00 0.00
Earnings Yield
— — — — (8.73%) (28.33%) (16.56%) (12.50%) (41.17%)
Free Cash Flow Yield
— — — — (8.73%) (13.57%) (13.20%) (9.32%) (24.81%)
Revenue per Share
— 0.00 0.00 0.00 0.03 0.16 0.18 0.19 0.20
Operating CF per Share
— (0.18) (0.22) (0.60) (0.79) (0.83) (0.79) (0.62) (0.63)
Capex per Share
— 0.00 0.00 (0.39) (0.48) (0.14) (0.06) (0.05) (0.06)
Free Cash Flow per Share
— (0.18) (0.22) (0.99) (1.27) (0.97) (0.85) (0.67) (0.69)
Cash per Share
— 0.00 0.32 5.99 1.84 1.49 1.46 0.98 0.76
Shareholders Equity per Share
— (0.31) (0.35) 6.47 6.06 4.15 3.47 3.22 2.16
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
— (0.31) (0.35) 6.47 6.06 4.15 3.47 3.22 2.16
Free Cash Flow
— (3.74) (5.65) (35.42) (61.22) (50.56) (48.08) (39.36) (45.00)
Working Capital
— (6.54) (10.63) 215.31 42.11 57.39 73.11 64.71 49.91
Capital Expenditures
— (0.07) (0.12) (13.94) (23.16) (7.17) (3.30) (2.77) (4.21)
Net Current Asset Value
— (6.54) (11.01) 214.39 23.84 45.21 65.50 57.80 44.36
EV/EBIT
— — — — 0.00 0.00 0.00 0.00 0.00
Capex to Sales
— 0.00 0.00 0.00 17.76 0.84 0.33 0.25 0.32
Price to Operating Income
— — — — 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
— 0.22 0.23 0.01 0.06 1.46 0.47 0.25 0.40
Cash ROIC
— 58.69% 3,138.33% (7.95%) (15.91%) (16.94%) (17.08%) (15.75%) (23.44%)
Accounts Receivable Turnover
— — — — 0.00 8.46 8.05 6.86 6.82
Accounts Payable Turnover
— 0.13 0.19 0.46 1.58 4.58 4.77 7.94 10.13
Inventory Turnover
— 0.00 0.00 0.00 0.00 0.00 0.00 11.38 11.31
Average Days of Payables
— 855.14 3,271.23 763.34 406.22 85.45 73.08 36.83 40.81
Days of Inventory on Hand
— 0.00 0.00 0.00 0.00 0.00 52.13 24.89 43.42
Average Receivables
— — — — — 1.01 1.23 1.64 1.91
Average Payables
— 0.28 0.28 0.46 1.78 3.38 3.46 2.76 2.55
Average Inventory
— — — — — — — 1.92 2.28
Average Assets
— 0.93 6.86 124.01 299.66 308.55 236.29 214.33 186.08
Average Common Equity
— (7.58) (7.58) 110.98 261.45 254.41 206.10 192.32 164.43

Fold the line items

Columns are period end dates